Sherbrooke Park Advisers »

Entrada Therapeutics shares owned by Sherbrooke Park Advisers

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Sherbrooke Park Advisers from 13F filings

Historical chart of Sherbrooke Park Advisers investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by Sherbrooke Park Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by Sherbrooke Park Advisers

Quarter filed Position value Share count Share price at filing
2025-09-30 $108k 19k 5.80
2024-09-30 $185k 12k 15.98

More positions owned by Sherbrooke Park Advisers

Airbnb Com Cl A (ABNB)
Duolingo Cl A Com (DUOL)
Atlassian Corporation Cl A (TEAM)
Bright Horizons Fam Sol In D (BFAM)
Iridium Communications (IRDM)
Metropcs Communications (TMUS)
Ringcentral Cl A (RNG)
Intuitive Surgical Com New (ISRG)
Darden Restaurants (DRI)
Hasbro (HAS)
Boston Scientific Corporation (BSX)
Gilead Sciences (GILD)
Amer Sports Com Shs (AS)
At&t (T)
Draftkings Com Cl A (DKNG)

View all positions for Sherbrooke Park Advisers

Top funds holding Entrada Therapeutics

Baker Bros. Advisors
MPM Asset Management
5AM Venture Management
BlackRock
Vanguard Group
Wellington Management Company
Millennium Management
StepStone
Geode Capital Management
Renaissance Technologies
TCG Crossover Management
State Street Corporation
Dimensional Fund Advisors
Royce & Associates
Citadel Advisors

View all funds holding Entrada Therapeutics